Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...

Hyderabad: India is harnessing science and genomics to build a skilled workforce and ensure timely diagnosis and treatment ...

Phase 3 SELVA study evaluating QTORIN rapamycin 3.9% anhydrous gel (QTORIN rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in Ma ...

A rare condition called Eosinophilic Fasciitis caused a 42-year-old engineer severe pain and stiffness. Doctors identified ...

Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative ...

That’s why I support the Constitutional Concealed Carry Reciprocity Act. This legislation ensures that law-abiding citizens ...

Dr Lata BichileMK, a 42-year-old engineer, walked into my OPD along with his wife in August 2023. He had been experiencing ...

Archana Puran Singh diagnosed with rare CRPS chronic pain condition after an injury, revealing how minor injuries can lead to ...

As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...

During the J.P. Morgan Healthcare Conference, VIVUS will share key highlights from 2025, demonstrating our commitment to ...

NASA satellites reveal swirling green algae in South Africa’s Hartbeespoort Dam. These blooms indicate nutrient pollution, ...